4 reports

THE DRUG CANDIDATE ACTS BY TARGETING DIPEPTIDASE-##.

  • Antifungal
  • Blood Disease
  • Diagnostics
  • Lung Cancer
  • Bristol-Myers Squibb Company

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Cancer
  • Diagnostics
  • Lung Cancer
  • Bristol-Myers Squibb Company

The drug candidate acts by blocking the histamine receptors and prevents the excess mucus production associated with ocular allergy.

  • Antifungal
  • Diagnostics
  • Ear Disease
  • Pharmaceutical
  • Sensorion S.A.

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Diagnostics
  • Lung Cancer
  • Monoclonal Antibody
  • SCYNEXIS, Inc.